Instead, Novo Nordisk, the Danish pharmaceutical company behind it, developed Wegovy, a nearly identical drug but at a higher dose, which is FDA-approved for weight loss
This guide is your trusted resource to help you have informed conversations with your doctor about weight and metabolic health
This suggests that high glucose can independently stimulate insulin secretion even when Gs activation is suppressed by pasireotide in GLP-1R-MIN-6 cells
Long-term clinical data shows that patients maintain weight loss as long as they continue tirzepatide, with additional benefits including improved blood sugar control and reduced cardiovascular risk markers
Its hard to separate what the supplement did from what the lifestyle changes did
The information provided on this site is for informational purposes only and should not be considered medical advice or a substitute for professional healthcare